At the DZFT, we have been developing prenatal therapies for many years, introducing them into clinical practice and then investigating the opportunities and risks of the new methods in retrospective or prospective studies.
We are currently working on
- the recording of long-term results after minimally invasive fetal surgery for spina bifida
- the investigation of long-term results of kidney function and the necessity of postnatal interventions in our collective of prenatally treated children with urinary tract obstructions
- the value of serial amniotic fluid replenishment to prevent the development of life-threatening lung hypoplasia in unborn children with renal insufficiency-related oligohydramnios
- the value of fetoscopic tracheal balloon occlusion to prevent the development of life-threatening lung hypoplasia in unborn babies after early premature rupture of membranes before the 20th week of pregnancy
- the recording of results after prenatal treatment of unborn babies with life-threatening lung malformations (CPAM)
- the development of fetoscopic laparoschisis for prenatal treatment of unborn babies with life-threatening diaphragmatic hernias
- the development of various techniques for amniotic membrane closure after fetoscopic fetal surgery
- a survey on the counseling experiences of pregnant women after prenatal diagnosis of a disease in their child
- the investigation of the value of chronic intermittent maternal-fetal hyperoxygenation (Kohl procedure) for the treatment of unborn children with underdeveloped left heart structures (HLHC, coarctation, ISTA)
- Investigation of the value of chronic intermittent maternal-fetal hyperoxygenation (Kohl procedure) for the treatment of severely underdeveloped ascending aorta in unborn babies with aortic valve atresia and hypoplastic left heart syndrome (HLHS)
- Investigations into maternal-fetal pain therapy in the context of prenatal intervention
